库马林 - 石灰的合成和药理特性
Donia Bensalah1, Nasser Amri2, Yousef E Mukhrish2
1Research Laboratory of Environmental Sciences and Technologies (LR16ES09), Higher Institute of Environmental Sciences and Technology, University of Carthage, Hammam-Lif, Tunisia.
MethodsX
|December 11, 2023
概括
合成了新的氨酸结合合金,并对其生物活性进行了测试. 化合物3a对抗癌细胞系表现出显著的抗菌,抗氧化和细胞毒性作用,在药物发现方面显示出前景.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药理学 药理学是指药理学的学科.
背景情况:
- 哈尔科纳和库马林是药物化学中的特权支架,以各种生物活动而闻名.
- 3-乙-4-基氨酸作为合成新型异环化合物的多功能前体.
研究的目的:
- 为了合成新的氨酸结合的烯酸衍生物.
- 评估合成的化合物对抗菌,抗氧化和抗癌活性.
主要方法:
- 克莱森 - 施密特凝结被用于石灰合成.
- 两步反应涉及反流和4-基氨酸,产生标化合物.
- 光谱技术 (NMR,IR) 和元素分析证实了结构.
- 在体外测试中评估了抗菌性,DPPH基因清除,基因清除和对HCT-116和HepG-2细胞系的细胞毒性活动.
主要成果:
- 一系列与氨酸结合的 (2a-e和3a-e) 已成功合成和表征.
- 这些化合物在体外对各种细菌菌株表现出显著的抗菌活性.
- 合成的化合物表现出显著的自由基清除特性.
- 化合物3a对结肠和肝细胞癌细胞系表现出有前途的细胞毒性活性,与芬布拉斯相当.
结论:
- 合成的氨酸结合石具有有前途的抗菌,抗氧化和抗癌性质.
- 化合物3a被确定为癌症治疗中进一步研究的主要候选物.
- 这项研究强调了修改库马林支架的潜力,以开发新的治疗剂.
更多相关视频
相关概念视频
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.2K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.2K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
988
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
988
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
569
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
569
Cholinergic Antagonists: Pharmacokinetics
453
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
453
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.2K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.2K
Drug Metabolism: Phase II Reactions
3.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.8K


